{"id":"https://openalex.org/W2148346557","doi":"https://doi.org/10.1161/01.cir.0000139333.83620.5d","title":"Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties","display_name":"Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties","publication_year":2004,"publication_date":"2004-08-10","ids":{"openalex":"https://openalex.org/W2148346557","doi":"https://doi.org/10.1161/01.cir.0000139333.83620.5d","mag":"2148346557","pmid":"https://pubmed.ncbi.nlm.nih.gov/15302796","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1513623"},"language":"en","primary_location":{"id":"doi:10.1161/01.cir.0000139333.83620.5d","doi":"https://doi.org/10.1161/01.cir.0000139333.83620.5d","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.cir.0000139333.83620.5d","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1513623","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005749391","display_name":"Charles N Antzelevitch","orcid":"https://orcid.org/0000-0001-7349-1582","observed_orcids":["https://orcid.org/0000-0001-7349-1582"]},"institutions":[{"id":"https://openalex.org/I4210088652","display_name":"Masonic Medical Research Laboratory","ror":"https://ror.org/004rs4477","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210088652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Antzelevitch","raw_affiliation_strings":["From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","Charles Antzelevitch From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]},{"raw_affiliation_string":"Charles Antzelevitch From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016568391","display_name":"Luiz Belardinelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088652","display_name":"Masonic Medical Research Laboratory","ror":"https://ror.org/004rs4477","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210088652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luiz Belardinelli","raw_affiliation_strings":["From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","Luiz Belardinelli From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]},{"raw_affiliation_string":"Luiz Belardinelli From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020349285","display_name":"Andrew C. Zygmunt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088652","display_name":"Masonic Medical Research Laboratory","ror":"https://ror.org/004rs4477","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210088652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew C. Zygmunt","raw_affiliation_strings":["From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","Andrew C. Zygmunt From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]},{"raw_affiliation_string":"Andrew C. Zygmunt From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062208796","display_name":"Alexander Burashnikov","orcid":"https://orcid.org/0000-0002-7198-0363","observed_orcids":["https://orcid.org/0000-0002-7198-0363"]},"institutions":[{"id":"https://openalex.org/I4210088652","display_name":"Masonic Medical Research Laboratory","ror":"https://ror.org/004rs4477","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210088652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Burashnikov","raw_affiliation_strings":["From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","Alexander Burashnikov From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]},{"raw_affiliation_string":"Alexander Burashnikov From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052720630","display_name":"Jos\u00e9 Mar\u00eda Di Diego","orcid":"https://orcid.org/0000-0003-4570-6659","observed_orcids":["https://orcid.org/0000-0003-4570-6659"]},"institutions":[{"id":"https://openalex.org/I4210088652","display_name":"Masonic Medical Research Laboratory","ror":"https://ror.org/004rs4477","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210088652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jose\u0301 M. Di Diego","raw_affiliation_strings":["From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111096386","display_name":"Jeffrey M. Fish","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088652","display_name":"Masonic Medical Research Laboratory","ror":"https://ror.org/004rs4477","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210088652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey M. Fish","raw_affiliation_strings":["From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","Jeffrey M. Fish From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]},{"raw_affiliation_string":"Jeffrey M. Fish From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019395807","display_name":"Jonathan M. Cordeiro","orcid":"https://orcid.org/0000-0002-4311-4599","observed_orcids":["https://orcid.org/0000-0002-4311-4599"]},"institutions":[{"id":"https://openalex.org/I4210088652","display_name":"Masonic Medical Research Laboratory","ror":"https://ror.org/004rs4477","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210088652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan M. Cordeiro","raw_affiliation_strings":["From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","Jonathan M. Cordeiro From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]},{"raw_affiliation_string":"Jonathan M. Cordeiro From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]}]},{"author_position":"last","author":{"id":null,"display_name":"George Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088652","display_name":"Masonic Medical Research Laboratory","ror":"https://ror.org/004rs4477","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210088652"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Thomas","raw_affiliation_strings":["From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","George Thomas From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]},{"raw_affiliation_string":"George Thomas From the Masonic Medical Research Laboratory, Utica, NY (C.A., A.C.Z., A.B., J.M.D., J.M.F., J.M.C., G.T.), and CV Therapeutics, Inc, Palo Alto, Calif (L.B.)","institution_ids":["https://openalex.org/I4210088652"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210088652"],"apc_list":null,"apc_paid":null,"fwci":21.7537,"has_fulltext":false,"cited_by_count":672,"citation_normalized_percentile":{"value":0.9962594,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"110","issue":"8","first_page":"904","last_page":"910"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11217","display_name":"Cardiac Arrhythmias and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ranolazine","display_name":"ranolazine","score":1.0},{"id":"https://openalex.org/keywords/antiarrhythmic-activity","display_name":"antiarrhythmic activity","score":0.7910000085830688},{"id":"https://openalex.org/keywords/antianginal-drugs","display_name":"antianginal drugs","score":0.902999997138977},{"id":"https://openalex.org/keywords/action-potential-duration","display_name":"action potential duration","score":0.5180000066757202},{"id":"https://openalex.org/keywords/transmural-dispersion-of-repolarization","display_name":"transmural dispersion of repolarization","score":0.9900000095367432},{"id":"https://openalex.org/keywords/late-sodium-current","display_name":"late sodium current","score":0.5920000076293945},{"id":"https://openalex.org/keywords/potassium-currents","display_name":"potassium currents","score":0.3779999911785126},{"id":"https://openalex.org/keywords/early-afterdepolarizations","display_name":"early afterdepolarizations","score":0.8679999709129333},{"id":"https://openalex.org/keywords/torsades-de-pointes","display_name":"torsades de pointes","score":0.953000009059906},{"id":"https://openalex.org/keywords/d-sotalol","display_name":"d-sotalol","score":0.7429999709129333},{"id":"https://openalex.org/keywords/amiodarone","display_name":"amiodarone","score":0.7910000085830688},{"id":"https://openalex.org/keywords/ventricular-myocytes","display_name":"ventricular myocytes","score":0.8339999914169312},{"id":"https://openalex.org/keywords/qt-interval-prolongation","display_name":"QT prolongation","score":0.6539999842643738}],"concepts":[{"id":"https://openalex.org/C2779177932","wikidata":"https://www.wikidata.org/wiki/Q907104","display_name":"Ranolazine","level":2,"score":0.9693007469177246},{"id":"https://openalex.org/C155730078","wikidata":"https://www.wikidata.org/wiki/Q2898697","display_name":"Afterdepolarization","level":4,"score":0.7810003161430359},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6880602240562439},{"id":"https://openalex.org/C146403970","wikidata":"https://www.wikidata.org/wiki/Q205729","display_name":"Repolarization","level":3,"score":0.671404242515564},{"id":"https://openalex.org/C185263204","wikidata":"https://www.wikidata.org/wiki/Q1154774","display_name":"Electrophysiology","level":2,"score":0.5374830961227417},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5045691728591919},{"id":"https://openalex.org/C118441451","wikidata":"https://www.wikidata.org/wiki/Q12074763","display_name":"QT interval","level":2,"score":0.4812295436859131},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4750545024871826},{"id":"https://openalex.org/C207200792","wikidata":"https://www.wikidata.org/wiki/Q428914","display_name":"Myocyte","level":2,"score":0.47268468141555786},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47166740894317627},{"id":"https://openalex.org/C2776639339","wikidata":"https://www.wikidata.org/wiki/Q413591","display_name":"Sotalol","level":3,"score":0.4515185058116913},{"id":"https://openalex.org/C2910096629","wikidata":"https://www.wikidata.org/wiki/Q241549","display_name":"Anti-Arrhythmia Agents","level":3,"score":0.41431742906570435},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069458","descriptor_name":"Ranolazine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000083","descriptor_name":"Acetanilides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000200","descriptor_name":"Action Potentials","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000889","descriptor_name":"Anti-Arrhythmia Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002118","descriptor_name":"Calcium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004562","descriptor_name":"Electrocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006352","descriptor_name":"Heart Ventricles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007473","descriptor_name":"Ion Channels","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009924","descriptor_name":"Organ Culture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011188","descriptor_name":"Potassium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012964","descriptor_name":"Sodium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017136","descriptor_name":"Ion Transport","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018408","descriptor_name":"Patch-Clamp Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019831","descriptor_name":"Sodium-Calcium Exchanger","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D024642","descriptor_name":"Potassium Channels, Voltage-Gated","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D032383","descriptor_name":"Myocytes, Cardiac","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051668","descriptor_name":"Delayed Rectifier Potassium Channels","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1161/01.cir.0000139333.83620.5d","doi":"https://doi.org/10.1161/01.cir.0000139333.83620.5d","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.cir.0000139333.83620.5d","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.490.5055","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.490.5055","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"http://circ.ahajournals.org/content/110/8/904.full.pdf","raw_type":"text"},{"id":"pmid:15302796","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15302796","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1513623","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1513623","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Circulation","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1513623","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1513623","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Circulation","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G380388557","display_name":null,"funder_award_id":"HL-47678","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G700104064","display_name":"Development of Novel Approaches for the Pharmacologic Treatment of Atrial Fibrill","funder_award_id":"R01HL047678","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320306230","display_name":"American Heart Association","ror":"https://ror.org/013kjyp64"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1944509346","https://openalex.org/W1970757917","https://openalex.org/W1976573783","https://openalex.org/W1980240868","https://openalex.org/W1980538198","https://openalex.org/W1993662648","https://openalex.org/W2005534939","https://openalex.org/W2013973612","https://openalex.org/W2020456708","https://openalex.org/W2027877139","https://openalex.org/W2049374127","https://openalex.org/W2049390983","https://openalex.org/W2054345442","https://openalex.org/W2058503109","https://openalex.org/W2060802584","https://openalex.org/W2075751878","https://openalex.org/W2080811832","https://openalex.org/W2084275033","https://openalex.org/W2088486084","https://openalex.org/W2124941371","https://openalex.org/W2135225379","https://openalex.org/W2136653489","https://openalex.org/W2149037176","https://openalex.org/W2149462844","https://openalex.org/W2174038367","https://openalex.org/W2269569055","https://openalex.org/W2298979802","https://openalex.org/W2466154807"],"related_works":["https://openalex.org/W1996934366","https://openalex.org/W1991325480","https://openalex.org/W163830645","https://openalex.org/W2003084475","https://openalex.org/W2090909285","https://openalex.org/W2001197934","https://openalex.org/W2316881465","https://openalex.org/W7097159075","https://openalex.org/W2014113446","https://openalex.org/W2752804697"],"abstract_inverted_index":{"BACKGROUND:":[0],"Ranolazine":[1,87,203,226],"is":[2],"a":[3,61,130],"novel":[4],"antianginal":[5,261],"agent":[6],"capable":[7],"of":[8,15,119,133,136,140,142,154,195,247],"producing":[9],"antiischemic":[10],"effects":[11,33,230],"at":[12,110,192],"plasma":[13],"concentrations":[14],"2":[16],"to":[17,146,205,232,249,259],"6":[18],"micromol/L":[19,161],"without":[20],"reducing":[21],"heart":[22],"rate":[23],"or":[24,116,121,148,200],"blood":[25],"pressure.":[26],"The":[27,245],"present":[28],"study":[29],"examines":[30],"its":[31,260],"electrophysiological":[32],"in":[34,151,198,216,257],"isolated":[35],"canine":[36],"ventricular":[37,44],"myocytes,":[38],"tissues,":[39],"and":[40,56,60,75,84,98,103,107,125,176,185,212,243,252],"arterially":[41],"perfused":[42],"left":[43],"wedge":[45,67,126],"preparations.":[46,68],"METHODS":[47],"AND":[48],"RESULTS:":[49],"Transmembrane":[50],"action":[51],"potentials":[52],"(APs)":[53],"from":[54,66,73,82],"epicardial":[55,74,83,137],"midmyocardial":[57],"(M)":[58],"regions":[59],"pseudo-ECG":[62],"were":[63,70,80,182],"recorded":[64,72,81],"simultaneously":[65],"APs":[69],"also":[71],"M":[76,85,143],"tissues.":[77],"Whole-cell":[78],"currents":[79],"myocytes.":[86],"inhibited":[88],"I(Kr)":[89,222],"(IC50=11.5":[90],"micromol/L),":[91,112],"late":[92,94,241],"I(Na),":[93,242],"I(Ca),":[95,97],"peak":[96],"I(Na-Ca)":[99],"(IC50=5.9,":[100],"50,":[101],"296,":[102],"91":[104],"micromol/L,":[105],"respectively)":[106],"I(Ks)":[108],"(17%":[109],"30":[111],"but":[113,138,169],"caused":[114],"little":[115],"no":[117,149],"inhibition":[118],"I(to)":[120],"I(K1).":[122],"In":[123],"tissues":[124],"preparations,":[127],"ranolazine":[128,162,248],"produced":[129],"concentration-dependent":[131],"prolongation":[132],"AP":[134],"duration":[135],"abbreviation":[139],"that":[141],"cells,":[144],"leading":[145],"reduction":[147],"change":[150],"transmural":[152],"dispersion":[153],"repolarization":[155],"(TDR).":[156],"At":[157],"[K+]o=4":[158],"mmol/L,":[159],"10":[160],"prolonged":[163],"QT":[164],"interval":[165],"by":[166,219],"20":[167,206],"ms":[168],"did":[170],"not":[171,189],"increase":[172,215],"TDR.":[173],"Extrasystolic":[174],"activity":[175],"spontaneous":[177],"torsade":[178],"de":[179],"pointes":[180],"(TdP)":[181],"never":[183],"observed,":[184],"stimulation-induced":[186],"TdP":[187],"could":[188],"be":[190],"induced":[191,218],"any":[193],"concentration":[194],"ranolazine,":[196],"either":[197],"normal":[199],"low":[201],"[K+]o.":[202],"(5":[204],"micromol/L)":[207],"suppressed":[208],"early":[209],"afterdepolarizations":[210],"(EADs)":[211],"reduced":[213],"the":[214,220,263],"TDR":[217,254],"selective":[221],"blocker":[223],"d-sotalol.":[224],"CONCLUSIONS:":[225],"produces":[227],"ion":[228],"channel":[229],"similar":[231],"those":[233],"observed":[234],"after":[235],"chronic":[236],"amiodarone":[237],"(reduced":[238],"I(Kr),":[239],"I(Ks),":[240],"I(Ca)).":[244],"actions":[246],"suppress":[250],"EADs":[251],"reduce":[253],"suggest":[255],"that,":[256],"addition":[258],"actions,":[262],"drug":[264],"may":[265],"possess":[266],"antiarrhythmic":[267],"activity.":[268]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":18},{"year":2022,"cited_by_count":20},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":26},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":25},{"year":2017,"cited_by_count":24},{"year":2016,"cited_by_count":35},{"year":2015,"cited_by_count":35},{"year":2014,"cited_by_count":40},{"year":2013,"cited_by_count":45},{"year":2012,"cited_by_count":49}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}